1. Home
  2. PPSI vs NTRB Comparison

PPSI vs NTRB Comparison

Compare PPSI & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$3.70

Market Cap

38.6M

Sector

Industrials

ML Signal

HOLD

Logo Nutriband Inc.

NTRB

Nutriband Inc.

N/A

Current Price

$4.60

Market Cap

71.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PPSI
NTRB
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Industrial Specialties
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.6M
71.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PPSI
NTRB
Price
$3.70
$4.60
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$12.00
$13.00
AVG Volume (30 Days)
52.2K
23.1K
Earning Date
11-13-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.86
N/A
Revenue
$31,751,000.00
$2,278,321.00
Revenue This Year
$26.84
$30.17
Revenue Next Year
$10.26
$3,394.36
P/E Ratio
$1.31
N/A
Revenue Growth
105.82
12.69
52 Week Low
$2.25
$3.72
52 Week High
$5.70
$11.78

Technical Indicators

Market Signals
Indicator
PPSI
NTRB
Relative Strength Index (RSI) 42.98 37.69
Support Level $3.62 $4.35
Resistance Level $4.24 $4.77
Average True Range (ATR) 0.22 0.42
MACD -0.03 0.03
Stochastic Oscillator 15.93 19.04

Price Performance

Historical Comparison
PPSI
NTRB

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: